Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization
Molly A. Sevcik, Joseph R. Ghilardi, Christopher M. Peters, Theodore H. Lindsay, Kyle G. Halvorson, Beth M. Jonas, Kazufumi Kubota, Michael A. Kuskowski, Leila Boustany, David L. Shelton, Patrick W. Mantyh
Dive into the research topics of 'Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization'. Together they form a unique fingerprint.